Form D · Biotechnology
PERSOWN Diagnostics, Inc.
Jacksonville, FL · CIK 0002034304
Offering snapshot reported Aug 21, 2024 · SEC filing
- Reported sold
- $10K Offering amount: $480K
- Investors reported
- 2 Form D · investor count
- Minimum accepted
- $1K Reported outside-investor minimum
- First sale
- Jul 17, 2024 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Aug 21, 2024 | Initial | $10,000 | No comparison | 2 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-522078
Source: Form D, filed Aug 21, 2024. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| William D Meadow | Director, Executive |
| Richard S Still | Director, Executive |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
10151 Deerwood Park Blvd Building 200, Suite 250
Jacksonville, FL, 32256
Jacksonville, FL, 32256